Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael E Rytting

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Current Hematologic Malignancy Reports|February 1, 2012
Lessons from ALL-REZ BFM 90: therapy for childhood leukemia based on timing and site of relapseMichael E Rytting
Current Hematology Reports|April 17, 2004
Pediatric myelodysplastic syndromesMichael E Rytting
The Lancet. Oncology|September 9, 2017
Questions on asparaginase-associated pancreatitisNaveen Pemmaraju, Michael E Rytting
Leukemia & Lymphoma|September 17, 2004
Central nervous system relapse in two patients with chronic myelogenous leukemia in myeloid blastic phase on imatinib mesylate therapyMichael E Rytting, William G Wierda
Clinical Lymphoma, Myeloma & Leukemia|December 10, 2014
Asparaginase in acute lymphoblastic leukemiaJitesh D Kawedia, Michael E Rytting
American Journal of Clinical Pathology|July 17, 2009
Acute lymphoblastic leukemia with Burkitt-like morphologic features and high myeloperoxidase activityMichael E Rytting, Hagop Kantarjian, Maher Albitar
JAAPA : Official Journal of the American Academy of Physician Assistants|September 9, 2010
A rapidly growing lymphoma and tumor lysis syndrome in a toddlerHolly L Green, Michael E Rytting, Charles S Cox
Lancet (London, England)|August 7, 2018
Acute myeloid leukaemiaNicholas J Short, Michael E Rytting, Jorge E Cortes
BMJ Case Reports|August 13, 2017
Acute myeloid leukaemia masquerading as a primary CNS tumourBranko Cuglievan, Brian A Menegaz, Sofia Garces, et al.
Pediatric Blood & Cancer|September 17, 2011
Advanced atypical teratoid/rhabdoid tumor (ATRT) treated with intensive multimodal approach shows continued response to sarcoma type salvage therapyVivek Subbiah, Johannes Wolff, Leena Ketonen, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Current Hematologic Malignancy Reports|February 1, 2012
Lessons from ALL-REZ BFM 90: therapy for childhood leukemia based on timing and site of relapseMichael E Rytting
Current Hematology Reports|April 17, 2004
Pediatric myelodysplastic syndromesMichael E Rytting
The Lancet. Oncology|September 9, 2017
Questions on asparaginase-associated pancreatitisNaveen Pemmaraju, Michael E Rytting
Leukemia & Lymphoma|September 17, 2004
Central nervous system relapse in two patients with chronic myelogenous leukemia in myeloid blastic phase on imatinib mesylate therapyMichael E Rytting, William G Wierda
Clinical Lymphoma, Myeloma & Leukemia|December 10, 2014
Asparaginase in acute lymphoblastic leukemiaJitesh D Kawedia, Michael E Rytting
American Journal of Clinical Pathology|July 17, 2009
Acute lymphoblastic leukemia with Burkitt-like morphologic features and high myeloperoxidase activityMichael E Rytting, Hagop Kantarjian, Maher Albitar
JAAPA : Official Journal of the American Academy of Physician Assistants|September 9, 2010
A rapidly growing lymphoma and tumor lysis syndrome in a toddlerHolly L Green, Michael E Rytting, Charles S Cox
Lancet (London, England)|August 7, 2018
Acute myeloid leukaemiaNicholas J Short, Michael E Rytting, Jorge E Cortes
BMJ Case Reports|August 13, 2017
Acute myeloid leukaemia masquerading as a primary CNS tumourBranko Cuglievan, Brian A Menegaz, Sofia Garces, et al.
Pediatric Blood & Cancer|September 17, 2011
Advanced atypical teratoid/rhabdoid tumor (ATRT) treated with intensive multimodal approach shows continued response to sarcoma type salvage therapyVivek Subbiah, Johannes Wolff, Leena Ketonen, et al.
Pageof 3